<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82331">
  <stage>Registered</stage>
  <submitdate>9/10/2007</submitdate>
  <approvaldate>25/10/2007</approvaldate>
  <actrnumber>ACTRN12607000550404</actrnumber>
  <trial_identification>
    <studytitle>Comparative study of visual and refractive outcomes of conventional coaxial phacoemulsification and microincision coaxial phacoemulsification</studytitle>
    <scientifictitle>Double blind randomized clinical trial of comparative study of surgically induced astigmatism, visual acuity, endothelial cell loss of conventional coaxial phacoemulsification and microincision coaxial phacoemulsification</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Cataract</healthcondition>
    <healthcondition>Cataract surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Microincision coaxial phacoemulsification: cataract surgery using phacoemulsification through 2.2 millimeters incision performed by Alcon Legacy machine.This procedure is done intra operatively</interventions>
    <comparator>Conventional coaxial phacoemulsification: cataract surgery performed through 2.8 millimeters incision using Alcon Legacy machine.This procedure is done intra operatively</comparator>
    <control>Active</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Surgically induced  astigmatism/keratometry/topography</outcome>
      <timepoint>1 month after surgery, 3months after surgery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Visual acuity using "EDTRS" (early treatment diabetic retinopaty study) chart</outcome>
      <timepoint>First day, 3 days, 1 month, 3 months after surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Endothelial cell loss using specular microscopy</outcome>
      <timepoint>3 months after surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Corneal thickness using pachymetry</outcome>
      <timepoint>First day, 3 days, 1 months, 3 months after surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time of surgery</outcome>
      <timepoint>Intra operative</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Intra operative used BSS (Balanced Salt Solution) volume</outcome>
      <timepoint>Intra operatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Corneal thickness using pachy metry</outcome>
      <timepoint>First day, 3 day ,1 month, 3 months after surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Effective phacoemulsification time</outcome>
      <timepoint>Intra operatively</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Senile cataract, no history of ocular surgery, 
no central corneal opacity, 7 milimeters or more pupil dilatation in preoperative exam, normal fundus exam, endothelial cell count more than 1600</inclusivecriteria>
    <inclusiveminage>25</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>-2147483648</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>More than 3 diopters astigmaism, expected visual scuity less than 20/40, zonulolysis, diabetes mellitus or other known metabolic disorders, pupil anomalies or posterior synechia, ocular disorders such as glaucoma, optic atrophy or intra ocular tumors
any drug abuse,
use of systemic corticosteroids or NSAIDS (non steroidal antiinflammatory drugs )since  1 month of surgery,
corneal opacity,
anyrenal ,hepatic ,endocrine ,pulmunar ,rheumatologic, neurologic and psycologic disorders</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelope</concealment>
    <sequence>Permuted block randomization</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>12/07/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>80</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Iran, Islamic Republic Of</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Tehran university of medical science</primarysponsorname>
    <primarysponsoraddress>Tehran University of Medical Science
Enghelab Street
Tehran</primarysponsoraddress>
    <primarysponsorcountry>Iran, Islamic Republic Of</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Tehran University of Medical Science</fundingname>
      <fundingaddress>Tehran University of Medical Science
Enghelab Street
Tehran</fundingaddress>
      <fundingcountry>Iran, Islamic Republic Of</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Noor Ophthalmology Research Center</sponsorname>
      <sponsoraddress>No 106 Esfandiar Blvd.
Vali'asr Ave.
Tehran</sponsoraddress>
      <sponsorcountry>Iran, Islamic Republic Of</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of the study is comparision of surgically induced astigmatism of conventional coaxial phacoemulsification and microincision coaxial phacoemulsification. Hypothesis of study is that surgically induced astigmatism is less using microincision cataract surgery in comparision with conventional coaxial phacoemulsification</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Narges Zandvakil</name>
      <address>Farabi Eye Hospital
Ghazvin Sq
Karegar Ave
Tehran</address>
      <phone>+98 21 88697000</phone>
      <fax />
      <email>zandvakil@razi.tums.ac.ir</email>
      <country>Iran, Islamic Republic Of</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Narges Zandvakil</name>
      <address>Farabi Eye Hospital
Ghazvin Sq
Karegar Ave
Tehran</address>
      <phone>+98 21 88697000</phone>
      <fax />
      <email>zandvakil@razi.tums.ac.ir</email>
      <country>Iran, Islamic Republic Of</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>